Removal of intrahepatic bile duct stone could reduce the risk of cholangiocarcinoma: A single-center retrospective study in South Korea.

BACKGROUND

Intrahepatic duct (IHD) stones are among the most important risk factors for cholangiocarcinoma (CCC). Approximately 10% of patients with IHD stones develop CCC; however, there are limited studies regarding the effect of IHD stone removal on CCC development.

AIM

To investigate the association between IHD stone removal and CCC development.

METHODS

We retrospectively analyzed 397 patients with IHD stones at a tertiary referral center between January 2011 and December 2020.

RESULTS

CCC occurred in 36 of the 397 enrolled patients. In univariate analysis, chronic hepatitis B infection (11.1% 3.0%, = 0.03), carbohydrate antigen 19-9 (CA19-9, 176.00 11.96 II/mL, = 0.010), stone located in left or both lobes (86.1% 70.1%, = 0.042), focal atrophy (52.8% 26.9%, = 0.001), duct stricture (47.2% 24.9%, = 0.004), and removal status of IHD stone (33.3% 63.2%, < 0.001) were significantly different between IHD stone patients with and without CCC. In the multivariate analysis, CA19-9 > upper normal limit, carcinoembryonic antigen > upper normal limit, stones located in the left or both lobes, focal atrophy, and complete removal of IHD stones without recurrence were independent factors influencing CCC development. However, the type of removal method was not associated with CCC risk.

CONCLUSION

Complete removal of IHD stones without recurrence could reduce CCC risk.